Polpharma to capture 10% of the pharmaceutical market?

One of the leading domestic pharmaceutical producers, Polpharma based in Starograd Gdanski, plans to invest zl. 330 million this year and to increase its market share to 10% within five years. "Sales in 2001 were 4% lower than expected but 24% higher than in 2000. This year I would like to increase domestic turnover by 30% and exports by 66%. Our revenues should reach zl. 820 million," said president of Polpharma Pavel Mirovski. He underlined the fact that the company had reduced its workforce by 1,100 workers and said that he hopes his company will soon rethink its product portfolio and pay special attention to generic drugs. (Puls Biznesu, p. 6) M.K.